| Synthesis of N1-arylidene-N2-quinolyl-and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains S Gemma, G Kukreja, C Fattorusso, M Persico, MP Romano, M Altarelli, ... Bioorganic & medicinal chemistry letters 16 (20), 5384-5388, 2006 | 248 | 2006 |
| Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives G Giannini, W Cabri, C Fattorusso, M Rodriquez Future medicinal chemistry 4 (11), 1439-1460, 2012 | 203 | 2012 |
| Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors L Savini, A Gaeta, C Fattorusso, B Catalanotti, G Campiani, L Chiasserini, ... Journal of Medicinal Chemistry 46 (1), 1-4, 2003 | 185 | 2003 |
| Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77 C Ferlini, L Cicchillitti, G Raspaglio, S Bartollino, S Cimitan, C Bertucci, ... Cancer research 69 (17), 6906-6914, 2009 | 181 | 2009 |
| Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives G Campiani, A Ramunno, G Maga, V Nacci, C Fattorusso, B Catalanotti, ... Current pharmaceutical design 8 (8), 615-657, 2002 | 163 | 2002 |
| The seco-taxane IDN5390 is able to target class III β-tubulin and to overcome paclitaxel resistance C Ferlini, G Raspaglio, S Mozzetti, L Cicchillitti, F Filippetti, D Gallo, ... Cancer research 65 (6), 2397-2405, 2005 | 134 | 2005 |
| Synthesis and Pharmacological Evaluation of Potent and Highly Selective D3 Receptor Ligands: Inhibition of Cocaine-Seeking Behavior and the Role of Dopamine D3/D … G Campiani, S Butini, F Trotta, C Fattorusso, B Catalanotti, F Aiello, ... Journal of medicinal chemistry 46 (18), 3822-3839, 2003 | 115 | 2003 |
| Discovery of a New Class of Potential Multifunctional Atypical Antipsychotic Agents Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors … S Butini, S Gemma, G Campiani, S Franceschini, F Trotta, M Borriello, ... Journal of medicinal chemistry 52 (1), 151-169, 2009 | 101 | 2009 |
| Design, synthesis, and structure–activity relationship studies of 4-quinolinyl-and 9-acrydinylhydrazones as potent antimalarial agents C Fattorusso, G Campiani, G Kukreja, M Persico, S Butini, MP Romano, ... Journal of medicinal chemistry 51 (5), 1333-1343, 2008 | 98 | 2008 |
| Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663 G Maga, S Gemma, C Fattorusso, GA Locatelli, S Butini, M Persico, ... Biochemistry 44 (28), 9637-9644, 2005 | 98 | 2005 |
| Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of … G Campiani, C Fattorusso, S Butini, A Gaeta, M Agnusdei, S Gemma, ... Journal of medicinal chemistry 48 (6), 1919-1929, 2005 | 90 | 2005 |
| Endoperoxide derivatives from marine organisms: 1, 2-dioxanes of the plakortin family as novel antimalarial agents C Fattorusso, G Campiani, B Catalanotti, M Persico, N Basilico, S Parapini, ... Journal of medicinal chemistry 49 (24), 7088-7094, 2006 | 80 | 2006 |
| Pyrrolo [1, 3] benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure− activity relationship studies, and identification of … G Campiani, S Butini, C Fattorusso, B Catalanotti, S Gemma, V Nacci, ... Journal of medicinal chemistry 47 (1), 143-157, 2004 | 79 | 2004 |
| Discovery of a new series of jatrophane and lathyrane diterpenes as potent and specific P-glycoprotein modulators E Barile, M Borriello, A Di Pietro, A Doreau, C Fattorusso, E Fattorusso, ... Organic & Biomolecular Chemistry 6 (10), 1756-1762, 2008 | 74 | 2008 |
| Novel and potent tacrine-related hetero-and homobivalent ligands for acetylcholinesterase and butyrylcholinesterase L Savini, G Campiani, A Gaeta, C Pellerano, C Fattorusso, L Chiasserini, ... Bioorganic & medicinal chemistry letters 11 (13), 1779-1782, 2001 | 71 | 2001 |
| Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors S Butini, G Campiani, M Borriello, S Gemma, A Panico, M Persico, ... Journal of medicinal chemistry 51 (11), 3154-3170, 2008 | 69 | 2008 |
| Neuronal high-affinity sodium-dependent glutamate transporters (EAATs): targets for the development of novel therapeutics against neurodegenerative diseases G Campiani, C Fattorusso, M Angelis, B Catalanotti, S Butini, R Fattorusso, ... Current pharmaceutical design 9 (8), 599-625, 2003 | 69 | 2003 |
| Oxime amides as a novel zinc binding group in histone deacetylase inhibitors: synthesis, biological activity, and computational evaluation CB Botta, W Cabri, E Cini, L De Cesare, C Fattorusso, G Giannini, ... Journal of Medicinal Chemistry 54 (7), 2165-2182, 2011 | 67 | 2011 |
| Combining 4-aminoquinoline-and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarials S Gemma, G Campiani, S Butini, BP Joshi, G Kukreja, SS Coccone, ... Journal of medicinal chemistry 52 (2), 502-513, 2009 | 67 | 2009 |
| Amygdaloidins A–L, twelve new 13 α-OH jatrophane diterpenes from Euphorbia amygdaloides L. G Corea, C Fattorusso, E Fattorusso, V Lanzotti Tetrahedron 61 (18), 4485-4494, 2005 | 67 | 2005 |
Bruno CatalanottiRicercatore in Chimica Farmaceutica, Università degli Studi di Napoli Federico IIDirección de correo verificada de unina.it
